5月19日消息，亿邦动力网获悉，贵州益佰制药今日宣布出资4100万元，完成了哈尔滨益佰医疗投资有限责任公司的注册，主营业务包括医院投资管理，医疗技术开发，医疗技术咨询，医院营销策划管理咨询。据亿邦动力网了解，哈尔滨益佰医疗投资有限责任公司注册资本8000万元，其中益佰制药出资4100万，占比51.25%；黑龙江世纪大恒投资管理有限公司出资3900万，占比48.75%，注册地点位于哈尔滨，其审议新公司最初定名为：黑龙江益佰肿瘤医疗投资管理有限公司。未来，益佰制药将协助世纪大恒制定肿瘤医院及肿瘤中心相关投资各项工作的整体规划。对新成立的投资公司来说，益佰制药负责帮助其开拓肿瘤医院及肿瘤治疗中心的相...
News, on May 19, hundred million bond power net, guizhou yi hundred pharmaceutical today announced a 41 million yuan, completed a Harbin yi hundred the registration of medical investment co., LTD., main business including hospital investment management, development of medical treatment, medical technology consulting, hospital marketing planning management consulting. Yi hundred million bond power net understand and Harbin medical investment co., LTD. Registered capital of 80 million yuan, the profit usd pharmaceutical $41 million, accounting for more than 51.25%; Heilongjiang century it investment management co., LTD., 39 million, accounted for 48.75%, registration site is located in Harbin, the initial review new company named: heilongjiang yi hundred tumor medical investment management co., LTD. In the future, good hundred pharmaceutical it will assist the century develop cancer hospital and cancer center related investment the overall planning of all work. For new investment company, yi hundred drug to help its pioneering cancer hospital and tumor treatment center phase...
